NET PROFIT (x1000 DKK)
EMPLOYEES
Pharma-Skan ApS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
14,742
|
13,945
|
11,627 |
Total assets |
23,561
|
23,501
|
21,112 |
Current assets |
23,287
|
23,319
|
20,871 |
Current liabilities |
3,507
|
4,480
|
3,925 |
Equity capital |
19,880
|
18,881
|
17,004 |
- share capital |
200
![]() |
200
![]() |
200 |
Employees (average) |
15
![]() |
15
![]() |
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
84.4%
|
80.3%
|
80.5% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
664.0%
|
520.5%
|
531.7% |
Return on equity (ROE) |
74.2%
|
73.9%
|
68.4% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.